Description
Report Scope
Bioresorbable polymers Market Overview
The bioresorbable polymers Market is projected to build a CAGR of 12.8% during the forecast time frame. Bioresorbable polymers are broadly utilized in the medical services sector, particularly in the medication conveyance framework.
The utilization of bioresorbable polymers in different applications, for example, muscular and dental is projected to help the interest in bioresorbable polymers during the forecast time frame. The utilization of bioresorbable polymers is prospering in the medical services industry as would be considered normal to drive the bioresorbable polymers market before very long.
Polymers have altogether added to the improvement of medication conveyance innovation by empowering the directed arrival of restorative specialists in steady doses overstretched periods, cyclic dosing, and different arrivals of both hydrophilic and hydrophobic drugs. The region has extended altogether from its beginning of utilizing normal materials.
The sane plan of polymers made to apply specific organic exercises and customized for a particular freight is presently the establishment for contemporary headways in drug conveyance.
In polymer treatments and nanomedicines, polymers have been utilized widely. Strong, for the most part round structures produced using natural or manufactured polymers are known as polymeric nanoparticles. One of the main natural purposes of polymeric nanoparticles is drug conveyance.
An assortment of medication conveyance frameworks, including small hydrophilic and hydrophobic drugs, immunizations, peptides, and natural macromolecules, have been tried to convey polymeric nanoparticles. The biodegradable polymers that produce polymeric nanoparticles most effectively incorporate different grades of poly(lactide-co-glycolide) and poly(lactide) copolymers.
Market Segmentation
Based on Type, the Bioresorbable polymers market type, includes agro-polymer and bio-polyesters.
Based on application, the market is classified into orthopedic, drug delivery, biodegradable devices, and others.
Regional Insights
North America overwhelmed the market with a portion of 44.03%, representing USD 578.60 million in 2021; it is normal to enlist the most noteworthy CAGR of 12.60% from 2022 to 2030.
Europe was the second biggest with a portion of 25.92% in 2021, estimated at USD 340.59 million; it is projected to show a CAGR of 11.9%.
The North American market is essentially determined by the accessibility of unrefined components and expanding interest in bioresorbable polymers across the region for different applications in clinical, drug, and others. Because of financial changes and expanded per capita pay, the medical services sector is growing all through North America, including the US and Canada.
Europe represents the second-biggest market share Bioresorbable polymers market is to a great extent provided by European nations like the UK and Germany. The developing interest in drug conveyance frameworks in the region is probably going to help the interest in the Bioresorbable polymers market. Further, the Germany Bioresorbable polymers market held the biggest market share and the quickest-developing market in the European region.
Major Players
Key Companies in the Bioresorbable polymers market are Evonik Industries AG, Corbion NV, Foster Corporation, Poly-Med Inc., REVA Medical, Inc. Groupe PCAS, Merck KGaA, Koninklijke DSM N.V, KLS Martin, and Ashland.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Table of Contets
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 MARKET DEFINITION
2.2 SCOPE OF THE STUDY
2.2.1 RESEARCH OBJECTIVES
2.2.2 ASSUMPTIONS & LIMITATIONS
2.3 MARKETS STRUCTURE
2.4 KEY TAKEAWAYS
3 MARKET RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
3.4 MARKET SIZE ESTIMATION
3.5 FORECAST MODEL
4 MARKET DYNAMICS OF GLOBAL BIORESORBABLE POLYMERS MARKET
4.1 INTRODUCTION
4.2 DRIVERS
4.3 RESTRAINTS
4.4 OPPORTUNITIES
4.5 CHALLENGES
4.6 TRENDS/TECHNOLOGY
5 MARKET FACTOR ANALYSIS OF GLOBAL BIORESORBABLE POLYMERS MARKET
5.1 SUPPLY CHAIN ANALYSIS
5.1.1 RAW MATERIAL SUPPLIERS
5.1.2 MANUFACTURERS/PRODUCERS
5.1.3 DISTRIBUTORS/RETAILERS/WHOLESALERS/E-COMMERCE
5.1.4 END USER
5.2 PORTER’S FIVE FORCES ANALYSIS
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 BARGAINING POWER OF SUPPLIERS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF COMPETITIVE RIVALRY
5.3 PRICING ANALYSIS
GLOBAL BIORESORBABLE POLYMERS MARKET, BY TYPE
6.1 INTRODUCTION
6.2 AGRO-POLYMERS
6.2.1 MARKET ESTIMATES & FORECAST, 2022-2030
6.2.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
6.2.2.1 PROTEINS
6.2.2.1.1 MARKET ESTIMATES & FORECAST, 2022-2030
6.2.2.1.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
6.2.2.2 POLYSACCHARIDES
6.2.2.2.1 MARKET ESTIMATES & FORECAST, 2022-2030
6.2.2.2.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
6.3 BIO-POLYESTERS
6.3.1 MARKET ESTIMATES & FORECAST, 2022-2030
6.3.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
6.3.2.1 POLYGLYCOLIC ACID
6.3.2.1.1 MARKET ESTIMATES & FORECAST, 2022-2030
6.3.2.1.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
6.3.2.2 POLYLACTIC ACID
6.3.2.2.1 MARKET ESTIMATES & FORECAST, 2022-2030
6.3.2.2.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
6.3.2.3 POLYCAPROLACTONE
6.3.2.3.1 MARKET ESTIMATES & FORECAST, 2022-2030
6.3.2.3.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
6.3.2.4 POLYDIOXANONE
6.3.2.4.1 MARKET ESTIMATES & FORECAST, 2022-2030
6.3.2.4.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
6.3.2.5 OTHERS
6.3.2.5.1 MARKET ESTIMATES & FORECAST, 2022-2030
6.3.2.5.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
GLOBAL BIORESORBABLE POLYMERS MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 ORTHOPEDICS
7.2.1 MARKET ESTIMATES & FORECAST, 2022-2030
7.2.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
7.3 DRUG DELIVERY
7.3.1 MARKET ESTIMATES & FORECAST, 2022-2030
7.3.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
7.4 OTHERS
7.4.1 MARKET ESTIMATES & FORECAST, 2022-2030
7.4.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
GLOBAL BIORESORBABLE POLYMERS MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.2.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.2.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.2.4 US
8.2.4.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.2.4.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.2.4.3 MARKET ESTIMATES & FORECAST, APPLICATION, 2022-2030
8.2.5 CANADA
8.2.5.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.2.5.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.2.5.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.3 EUROPE
8.3.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.3.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.3.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.3.4 GERMANY
8.3.4.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.3.4.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.3.4.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.3.5 FRANCE
8.3.5.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.3.5.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.3.5.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.3.6 ITALY
8.3.6.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.3.6.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.3.6.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.3.7 SPAIN
8.3.7.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.3.7.2 MARKET ESTIMATES & FORECAST, BY TYPE,2022-2030
8.3.7.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.3.8 UK
8.3.8.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.3.8.2 MARKET ESTIMATES & FORECAST, BY TYPE,2022-2030
8.3.8.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.3.9 RUSSIA
8.3.9.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.3.9.2 MARKET ESTIMATES & FORECAST, BY TYPE,2022-2030
8.3.9.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.3.10 POLAND
8.3.10.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.3.10.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.3.10.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.3.11 REST OF EUROPE
8.3.11.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.3.11.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.3.11.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.4 ASIA-PACIFIC
8.4.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.4.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.4.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.4.4 CHINA
8.4.4.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.4.4.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.4.4.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.4.5 INDIA
8.4.5.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.4.5.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.4.5.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.4.6 JAPAN
8.4.6.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.4.6.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.4.6.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.4.7 AUSTRALIA & NEW ZEALAND
8.4.7.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.4.7.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.4.7.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.4.8 REST OF ASIA-PACIFIC
8.4.8.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.4.8.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.4.8.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.5 MIDDLE EAST & AFRICA
8.5.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.5.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.5.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.5.4 GCC
8.5.4.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.5.4.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.5.4.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.5.5 ISRAEL
8.5.5.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.5.5.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.5.5.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.5.6 NORTH AFRICA
8.5.6.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.5.6.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.5.6.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.5.7 TURKEY
8.5.7.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.5.7.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.5.7.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.5.8 REST OF MIDDLE EAST & AFRICA
8.5.8.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.5.8.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.5.8.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.6 LATIN AMERICA
8.6.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.6.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.6.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.6.4 BRAZIL
8.6.4.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.6.4.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.6.4.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.6.5 ARGENTINA
8.6.5.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.6.5.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.6.5.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.6.6 MEXICO
8.6.6.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.6.6.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.6.6.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
8.6.7 REST OF LATIN AMERICA
8.6.7.1 MARKET ESTIMATES & FORECAST, 2022-2030
8.6.7.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
8.6.7.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
COMPANY LANDSCAPE
9.1 INTRODUCTION
9.2 MARKET STRATEGY
9.3 KEY DEVELOPMENT ANALYSIS (EXPANSION/MERGER & ACQUISITIONS/JOINT VENTURE/NEW PRODUCT DEVELOPMENT/AGREEMENT/INVESTMENT)
COMPANY PROFILES
10.1 EVONIK INDUSTRIES AG
10.1.1 COMPANY OVERVIEW
10.1.2 FINANCIAL UPDATES
10.1.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.1.4 STRATEGY
10.1.5 KEY DEVELOPMENTS
10.1.6 SWOT ANALYSIS
10.2 CORBION NV
10.2.1 COMPANY OVERVIEW
10.2.2 FINANCIAL UPDATES
10.2.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.2.4 STRATEGY
10.2.5 KEY DEVELOPMENTS
10.2.6 SWOT ANALYSIS
10.3 FOSTER CORPORATION.
10.3.1 COMPANY OVERVIEW
10.3.2 FINANCIAL UPDATES
10.3.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.3.4 STRATEGY
10.3.5 KEY DEVELOPMENTS
10.3.6 SWOT ANALYSIS
10.4 POLY-MED INC.
10.4.1 COMPANY OVERVIEW
10.4.2 FINANCIAL UPDATES
10.4.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.4.4 STRATEGY
10.4.5 KEY DEVELOPMENTS
10.4.6 SWOT ANALYSIS
10.5 DURECT CORPORATION
10.5.1 COMPANY OVERVIEW
10.5.2 FINANCIAL UPDATES
10.5.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.5.4 STRATEGY
10.5.5 KEY DEVELOPMENTS
10.5.6 SWOT ANALYSIS
10.6 MERCK KGAA
10.6.1 COMPANY OVERVIEW
10.6.2 FINANCIAL UPDATES
10.6.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.6.4 STRATEGY
10.6.5 KEY DEVELOPMENTS
10.6.6 SWOT ANALYSIS
10.7 KONINKLIJKE DSM N.V
10.7.1 COMPANY OVERVIEW
10.7.2 FINANCIAL UPDATES
10.7.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.7.4 STRATEGY
10.7.5 KEY DEVELOPMENTS
10.7.6 SWOT ANALYSIS
10.8 KLS MARTIN
10.8.1 COMPANY OVERVIEW
10.8.2 FINANCIAL UPDATES
10.8.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.8.4 STRATEGY
10.8.5 KEY DEVELOPMENTS
10.8.6 SWOT ANALYSIS
10.9 ASHLAND
10.9.1 COMPANY OVERVIEW
10.9.2 FINANCIAL UPDATES
10.9.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.9.4 STRATEGY
10.9.5 KEY DEVELOPMENTS
10.9.6 SWOT ANALYSIS
10.10 PUTNAM PLASTICS
10.10.1 COMPANY OVERVIEW
10.10.2 FINANCIAL UPDATES
10.10.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.10.4 STRATEGY
10.10.5 KEY DEVELOPMENTS
10.10.6 SWOT ANALYSIS
10.11 GROUPE PCAS
10.11.1 COMPANY OVERVIEW
10.11.2 FINANCIAL UPDATES
10.11.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.11.4 STRATEGY
10.11.5 KEY DEVELOPMENTS
10.11.6 SWOT ANALYSIS
10.12 REVA MEDICAL, INC
10.12.1 COMPANY OVERVIEW
10.12.2 FINANCIAL UPDATES
10.12.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.12.4 STRATEGY
10.12.5 KEY DEVELOPMENTS
10.12.6 SWOT ANALYSIS
CONCLUSION
